Efficacy and Safety of Using Combination of 755-nm Picosecond Alexandrite Laser and 2% Hydroquinone Compared With 2% Hydroquinone Alone for the Treatment of Melasma: a Randomized Split-face Controlled Trial

• Status: Recruiting
• Trial end date: 2021-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to assess the efficacy and safety of using combination of 755-nm picosecond alexandrite laser and 2% hydroquinone compared with 2% hydroquinone alone for the treatment of melasma: A randomized split-face controlled trial

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mahidol University
• Treatments: Hydroquinone

Criteria

Inclusion Criteria:

• Both male and female age 18-60 years

• Melasma on both cheeks - epidermal or mixed type

• Fitzpatrick Skin type III-V

Exclusion Criteria:

• History of retinoid or other keratolytic drugs used within 6 months before enrolled

• History of keloid

• photosensitivity

• Immunocompromised host